The AstraZeneca-University of Maryland Clinical Development Fellowship is an exclusive 2-year program geared toward PharmD and PhD graduates with a penchant for clinical research in the pharmaceutical and biotechnology industries. Established in 2009, the fellowship has paved the career path for numerous to enter clinical development.<\/p>\n
Two fellowship position will be recruited for in the 2026-2028 cycle:
\n1. PharmD Fellow \u2013 located at the Boston, MA or Gaithersburg, MD office
\n2. PhD Fellow \u2013 located at the Gaithersburg, MD office Fellows in the program will be involved in the early clinical development of oncology therapeutics. These pharmaceutical products may include biologics and small molecules, as well as exciting new modalities (including ADCs and Immunotherapies).<\/p>\n
<\/p>\n
The key learning objectives of the fellowship program are to understand: \u2022 Scientific research process (including hypothesis generation and development) \u2022 Clinical Development role and part of a Study Team \u2022 Protocol development and study design \u2022 Clinical development plans \u2022 Understanding of oncology efficacy and safety assessments \u2022 Data analysis, interpretation, and presentation \u2022 Preparation and review of safety narratives \u2022 Presentation to internal and external stakeholders \u2022 Professional communication including verbal and written \u2022 Preceptorship of 4th year PharmD students from University of Maryland<\/p>\n
<\/p>\n